Abstract

Objective: Existing data showed that left ventricular diastolic dysfunction is common in individuals with type 2 diabetes mellitus (T2DM). However, most of the studies included diabetic patients who have prior cardiovascular disease, which might be the compounding factor for ventricular dysfunction. This study aimed to determine the prevalence and predictors of left ventricular diastolic dysfunction in an Asian population with T2DM without prior cardiovascular disease using the latest recommended echocardiographic assessment for left ventricular diastolic dysfunction.Design and Participants: This is a cross-sectional study in which eligible patients with T2DM without history of coronary artery disease, heart failure, or valvular heart disease were recruited. Demographic data, diabetic control, comorbidities, microvascular/macrovascular complications, and medications prescribed were recorded. Venous blood was sent to test for B-type natriuretic peptide, and transthoracic echocardiography was performed to assess left ventricular dysfunction.Setting: This study was performed in a tertiary healthcare center located in Kuala Lumpur, Malaysia.Results: Of the 301 patients, 83.1% have had T2DM for >10 years, with 45.8% being poorly controlled. Comorbidities include hypertension (77.1%), hyperlipidemia (91.0%), and pre-obesity/obesity (72.9%). Majority had absence of microvascular (albuminuria, retinopathy, and neuropathy) and macrovascular (peripheral vascular disease and stroke) complications. None had raised B-type natriuretic peptide levels, and 93.7% had no symptoms of heart failure. On echocardiographic assessment, 70.1% had left ventricular diastolic dysfunction, and 90.5% had Grade 1/mild severity. Age, ethnicity, insulin therapy, presence of hypertension, and hyperlipidemia were significantly associated with left ventricular diastolic dysfunction. Older T2DM patients of Chinese ethnicity and on insulin are about two times more likely to develop left ventricular diastolic dysfunction.Conclusion: There was a high prevalence of asymptomatic left ventricular diastolic dysfunction among patients with T2DM without prior known cardiovascular disease. Older age, insulin therapy, and Chinese ethnicity were risk factors for left ventricular diastolic dysfunction in T2DM.

Highlights

  • Heart failure (HF) is an important cause of morbidity and mortality in type 2 diabetes mellitus (T2DM) [1]

  • The American Society of Echocardiography (ASE)/European Association of Cardiovascular Imaging (EACVI) 2016 [6] recommendations introduced an uncomplicated method to diagnose and grade the severity of left ventricular diastolic dysfunction (LVDD). Echocardiographic parameters such as left atrium volume index, tricuspid regurgitation velocity, E/e′, and septal or lateral e′ velocity were used for the diagnosis of LVDD in the presence of normal left ventricular ejection fraction (LVEF), whereas the diagnosis of HF with preserved ejection fraction (HFpEF) incorporates clinical signs and symptoms of HF, presence of LVDD on echocardiography (ECHO), and rise in biomarkers [B-type natriuretic peptide (BNP)]

  • We found that none of our multiethnic high-risk Asian cohort with long-standing T2DM had evidence of left ventricular systolic dysfunction (LVSD) on echocardiography

Read more

Summary

Introduction

Heart failure (HF) is an important cause of morbidity and mortality in type 2 diabetes mellitus (T2DM) [1]. The American Society of Echocardiography (ASE)/European Association of Cardiovascular Imaging (EACVI) 2016 [6] recommendations introduced an uncomplicated method to diagnose and grade the severity of LVDD. Echocardiographic parameters such as left atrium volume index, tricuspid regurgitation velocity, E/e′, and septal or lateral e′ velocity were used for the diagnosis of LVDD in the presence of normal left ventricular ejection fraction (LVEF), whereas the diagnosis of HF with preserved ejection fraction (HFpEF) incorporates clinical signs and symptoms of HF, presence of LVDD on echocardiography (ECHO), and rise in biomarkers [B-type natriuretic peptide (BNP)]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.